These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 33044013)

  • 21. Evaluation of machine learning-based classification of clinical impairment and prediction of clinical worsening in multiple sclerosis.
    Noteboom S; Seiler M; Chien C; Rane RP; Barkhof F; Strijbis EMM; Paul F; Schoonheim MM; Ritter K
    J Neurol; 2024 Aug; 271(8):5577-5589. PubMed ID: 38909341
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stages of brain volume loss and performance in the Brief International Cognitive Assessment for Multiple Sclerosis.
    Miyazaki Y; Niino M; Takahashi E; Nomura T; Naganuma R; Amino I; Akimoto S; Minami N; Kikuchi S
    Mult Scler Relat Disord; 2022 Nov; 67():104183. PubMed ID: 36116381
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cost and Quality of Life of Disability Progression in Multiple Sclerosis Beyond EDSS: Impact of Cognition, Fatigue, and Limb Impairment.
    Wasem J; Heer Y; Karamasioti E; Muros-Le Rouzic E; Marcelli G; Di Maio D; Braune S; Kobelt G; Dillon P
    Pharmacoecon Open; 2024 Sep; 8(5):665-678. PubMed ID: 38949748
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Feasibility of detecting atrophy relevant for disability and cognition in multiple sclerosis using 3D-FLAIR.
    Noteboom S; van Nederpelt DR; Bajrami A; Moraal B; Caan MWA; Barkhof F; Calabrese M; Vrenken H; Strijbis EMM; Steenwijk MD; Schoonheim MM
    J Neurol; 2023 Nov; 270(11):5201-5210. PubMed ID: 37466663
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sub-millimeter imaging of brain-free water for rapid volume assessment in atrophic brains.
    Gao KC; Nair G; Cortese IC; Koretsky A; Reich DS
    Neuroimage; 2014 Oct; 100():370-8. PubMed ID: 24945671
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Digital outcome measures are associated with brain atrophy in patients with multiple sclerosis.
    Molenaar PCG; Noteboom S; van Nederpelt DR; Krijnen EA; Jelgerhuis JR; Lam KH; Druijff-van de Woestijne GB; Meijer KA; van Oirschot P; de Jong BA; Brouwer I; Jasperse B; de Groot V; Uitdehaag BMJ; Schoonheim MM; Strijbis EMM; Killestein J
    J Neurol; 2024 Sep; 271(9):5958-5968. PubMed ID: 39008036
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vulnerability of Thalamic Nuclei at CSF Interface During the Entire Course of Multiple Sclerosis.
    Koubiyr I; Yamamoto T; Blyau S; Kamroui RA; Mansencal B; Planche V; Petit L; Saranathan M; Casey R; Ruet A; Brochet B; Manjón JV; Dousset V; Coupé P; Tourdias T;
    Neurol Neuroimmunol Neuroinflamm; 2024 May; 11(3):e200222. PubMed ID: 38635941
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enlarged choroid plexus related to iron rim lesions and deep gray matter atrophy in relapsing-remitting multiple sclerosis.
    Wang X; Zhu Q; Yan Z; Shi Z; Xu Y; Liu Y; Li Y
    Mult Scler Relat Disord; 2023 Jul; 75():104740. PubMed ID: 37146422
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impairment of daily occupations in multiple sclerosis: analysis of neuroimaging, general and social cognition, and reserve.
    Gomes LR; Damasceno BP; de Campos BM; Damasceno A
    Mult Scler Relat Disord; 2024 Jan; 81():105140. PubMed ID: 37988860
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The volume and structural covariance network of thalamic nuclei in patients with Wilson's disease: an investigation of the association with neurological impairment.
    Zhang B; Yang G; Xu C; Zhang R; He X; Hu W
    Neurol Sci; 2024 May; 45(5):2063-2073. PubMed ID: 38049551
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Impact of Intracortical Lesions on Volumes of Subcortical Structures in Multiple Sclerosis.
    Kalinin I; Makshakov G; Evdoshenko E
    AJNR Am J Neuroradiol; 2020 May; 41(5):804-808. PubMed ID: 32381540
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MRI Markers and Functional Performance in Patients With CIS and MS: A Cross-Sectional Study.
    Rasche L; Scheel M; Otte K; Althoff P; van Vuuren AB; Gieß RM; Kuchling J; Bellmann-Strobl J; Ruprecht K; Paul F; Brandt AU; Schmitz-Hübsch T
    Front Neurol; 2018; 9():718. PubMed ID: 30210439
    [No Abstract]   [Full Text] [Related]  

  • 33. Validation of the Brief International Cognitive Assessment for Multiple Sclerosis in Japan.
    Niino M; Fukazawa T; Kira JI; Okuno T; Mori M; Sanjo N; Ohashi T; Fukaura H; Fujimori J; Shimizu Y; Mifune N; Miyazaki Y; Takahashi E; Kikuchi S; Langdon D; Hb Benedict R; Matsui M
    Mult Scler J Exp Transl Clin; 2017; 3(4):2055217317748972. PubMed ID: 29339837
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical Relevance of Multiparametric MRI Assessment of Cervical Cord Damage in Multiple Sclerosis.
    Bonacchi R; Pagani E; Meani A; Cacciaguerra L; Preziosa P; De Meo E; Filippi M; Rocca MA
    Radiology; 2020 Sep; 296(3):605-615. PubMed ID: 32573387
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structural and functional correlates of disability, motor and cognitive performances in multiple sclerosis: Focus on the globus pallidus.
    Romanò F; Valsasina P; Pagani E; De Simone A; Parolin E; Filippi M; Rocca MA
    Mult Scler Relat Disord; 2024 Jun; 86():105576. PubMed ID: 38579567
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predicting disability progression and cognitive worsening in multiple sclerosis using patterns of grey matter volumes.
    Colato E; Stutters J; Tur C; Narayanan S; Arnold DL; Gandini Wheeler-Kingshott CAM; Barkhof F; Ciccarelli O; Chard DT; Eshaghi A
    J Neurol Neurosurg Psychiatry; 2021 Sep; 92(9):995-1006. PubMed ID: 33879535
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Multiple Sclerosis Functional Composite and Symbol Digit Modalities Test as outcome measures in pediatric multiple sclerosis.
    Brenton JN; Koshiya H; Woolbright E; Goldman MD
    Mult Scler J Exp Transl Clin; 2019; 5(2):2055217319846141. PubMed ID: 31065380
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thalamic asymmetry in Multiple Sclerosis.
    Ramezani N; Davanian F; Naghavi S; Riahi R; Zandieh G; Danesh-Mobarhan S; Ashtari F; Shaygannejad V; Sanayei M; Adibi I
    Mult Scler Relat Disord; 2023 Sep; 77():104853. PubMed ID: 37473593
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The association between cognition and motor performance is beyond structural damage in relapsing-remitting multiple sclerosis.
    Mistri D; Cacciaguerra L; Storelli L; Meani A; Cordani C; Rocca MA; Filippi M
    J Neurol; 2022 Aug; 269(8):4213-4221. PubMed ID: 35278104
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intrinsic and extrinsic contributors to subregional thalamic volume loss in multiple sclerosis.
    Krijnen EA; Salim Karam E; Russo AW; Lee H; Chiang FL; Schoonheim MM; Huang SY; Klawiter EC
    Ann Clin Transl Neurol; 2024 Jun; 11(6):1405-1419. PubMed ID: 38725151
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.